Search

Your search keyword '"Gleason scores"' showing total 122 results

Search Constraints

Start Over You searched for: Descriptor "Gleason scores" Remove constraint Descriptor: "Gleason scores" Search Limiters Full Text Remove constraint Search Limiters: Full Text
122 results on '"Gleason scores"'

Search Results

1. Federated Learning with Research Prototypes: Application to Multi-Center MRI-based Detection of Prostate Cancer with Diverse Histopathology.

2. Differential analysis of histopathological and genetic markers of cancer aggressiveness, and survival difference in EBV-positive and EBV-negative prostate carcinoma

3. Differential analysis of histopathological and genetic markers of cancer aggressiveness, and survival difference in EBV-positive and EBV-negative prostate carcinoma.

4. Machine learning techniques on homological persistence features for prostate cancer diagnosis

5. A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen

6. A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk.

7. A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen < 10 ng/mL.

8. Machine learning techniques on homological persistence features for prostate cancer diagnosis.

9. Increased Density of Growth Differentiation Factor-15+ Immunoreactive M1/M2 Macrophages in Prostate Cancer of Different Gleason Scores Compared with Benign Prostate Hyperplasia.

10. A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk

11. Inferring Personalized and Race-Specific Causal Effects of Genomic Aberrations on Gleason Scores: A Deep Latent Variable Model

12. Inferring Personalized and Race-Specific Causal Effects of Genomic Aberrations on Gleason Scores: A Deep Latent Variable Model.

13. The added value of PSMA PET/MR radiomics for prostate cancer staging

14. Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 Era Versus the Post-ISUP2014 Era

15. Tissue Zinc Concentration in Prostate Cancer: Relationship with Prostate Specific Antigen and Gleason Score in a Cohort of Nigerian Men

16. Predictive value of standard serum markers for bone metastases in prostate cancer

17. Concordance Between Biopsy and Radical Prostatectomy Gleason Scores: Evaluation of Determinants in a Large-Scale Study of Patients Undergoing RARP in Belgium

19. Can the Irisin be a Biomarker for Prostate Cancer? A Case Control Study

20. Increased Density of Growth Differentiation Factor-15+ Immunoreactive M1/M2 Macrophages in Prostate Cancer of Different Gleason Scores Compared with Benign Prostate Hyperplasia

21. The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues

22. Artificial intelligence-based measurements of PET/CT imaging biomarkers are associated with disease-specific survival of high-risk prostate cancer patients

23. Prostate cancer markers: An update (Review).

24. Correlation of serum PSA levels with Gleason score in patients with prostatic Adenocarcinoma

25. Gleason grading of prostate cancer: a pragmatic approach

26. Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging

27. High Inter- and Intratumoral Variability of Ki67 Labeling Index in Newly Diagnosed Prostate Cancer with High Gleason Scores

28. Mapping prostatic microscopic anisotropy using linear and spherical b-tensor encoding: A preliminary study

29. Robust treatment planning of dose painting for prostate cancer based on ADC-to-Gleason score mappings : what is the potential to increase the tumor control probability?

30. Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups?

31. ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer?

32. Gleason Score Evolution and the Effect on Prostate Cancer Outcomes

33. The Reliability of Self-Reported Gleason Scores in Studies of Sexual Minority Prostate Cancer Survivors

34. Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer

35. The performance of 18F-PSMA PET/CT in the detection of prostate cancer: a systematic review and meta-analysis

36. Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

37. Expression of stromal elements of prostatic adenocarcinoma in different gleason scores

38. Racial Disparities in Clinically Significant Prostate Cancer Treatment: The Potential Health Information Technology Offers

39. Dose painting of prostate cancer based on Gleason score correlations with apparent diffusion coefficients

40. A Natural Language Processing–Assisted Extraction System for Gleason Scores: Development and Usability Study

41. Kemik Sintigrafisi Sonuçları ile Gleason Skor ve Prostat- Spesifik Antijen Düzeyleri Arasındaki İlişki

42. Reliability of multiparametric prostatic MRI quantitative data in the evaluation of prostate cancer aggressiveness

43. Plasma microRNA signature is associated with risk stratification in prostate cancer patients

44. Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason scores: a preliminary report.

45. A Hierarchical Machine Learning Model to Discover Gleason Grade-Specific Biomarkers in Prostate Cancer

46. Assessment of the Utility of Gene Positioning Biomarkers in the Stratification of Prostate Cancers

47. Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA

48. A Bayesian multi-risks survival (MRS) model in the presence of double censorings

49. Clinical significance of neutrophil-lymphocyte ratio in patients with low-risk prostate cancer

50. Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population

Catalog

Books, media, physical & digital resources